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on short-chain alcohols
Georg Basler1,2*, Mitchell Thompson3,4, Danielle Tullman‑Ercek5,6,7 and Jay Keasling1,4,8,9
Abstract 
Background: The microbial production of biofuels is complicated by a tradeoff between yield and toxicity of many 
fuels. Efflux pumps enable bacteria to tolerate toxic substances by their removal from the cells while bypassing the 
periplasm. Their use for the microbial production of biofuels can help to improve cell survival, product recovery, and 
productivity. However, no native efflux pump is known to act on the class of short‑chain alcohols, important next‑
generation biofuels, and it was considered unlikely that such an efflux pump exists.
Results: We report that controlled expression of the RND‑type efflux pump TtgABC from Pseudomonas putida 
DOT‑T1E strongly improved cell survival in highly toxic levels of the next‑generation biofuels n‑butanol, isobutanol, 
isoprenol, and isopentanol. GC‑FID measurements indicated active efflux of n‑butanol when the pump is expressed. 
Conversely, pump expression did not lead to faster growth in media supplemented with low concentrations of 
n‑butanol and isopentanol.
Conclusions: TtgABC is the first native efflux pump shown to act on multiple short‑chain alcohols. Its controlled 
expression can be used to improve cell survival and increase production of biofuels as an orthogonal approach to 
metabolic engineering. Together with the increased interest in P. putida for metabolic engineering due to its flexible 
metabolism, high native tolerance to toxic substances, and various applications of engineering its metabolism, our 
findings endorse the strain as an excellent biocatalyst for the high‑yield production of next‑generation biofuels.
Keywords: Higher alcohols, Short‑chain alcohols, Next‑generation biofuels, Efflux pumps, TtgABC, Pseudomonas 
putida, Tolerance, Toxicity
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Background
The high tolerance of several gram-negative bacte-
ria to toxic substances compared to other organisms 
is attributed to a lower outer membrane permeability, 
periplasmic and cytosolic enzymatic degradation (e.g., 
β-lactamases), homeoviscous membrane adaptation, and 
multidrug efflux pumps [1–3]. The latter have the poten-
tial not only to improve cell survival in toxic environ-
ments, but also to directly increase yield and productivity 
of production strains by removing the final product from 
the cells and facilitating extracellular product recovery 
[4]. Consequently, the discovery of efflux pumps act-
ing on a target product of interest can help to improve 
microbial production, particularly of toxic substances, 
such as antibiotics or biofuels [5–7].
Various strains of Pseudomonas are known for their 
ability to metabolize a number of industrial products 
and solvents as sole carbon source [8, 9], and to toler-
ate high concentrations of toxic aromatic compounds 
[10–13]. The strain Pseudomonas putida DOT-T1E was 
isolated from a wastewater plant in Spain [14], and pos-
sesses a number of efflux systems. TtgABC is an efflux 
system of the resistance-nodulation-cell division (RND) 
type consisting of the inner membrane protein TtgB, the 
membrane fusion protein TtgA, and the outer membrane 
channel TtgC [15, 16]. TtgABC is expressed constitutively 
[15], but is also assumed to be induced by n-butanol 
[17]. It acts on specific aromatic hydrocarbons, such as 
toluene, m-xylene, and 1,2,4-trichlorobenzene, as well as 
antibiotics [15], in combination with the efflux systems 
Open Access
Biotechnology for Biofuels
*Correspondence:  basler@mpimp‑golm.mpg.de 
1 Department of Chemical and Biomolecular Engineering, University 
of California, Berkeley, CA, USA
Full list of author information is available at the end of the article
Page 2 of 10Basler et al. Biotechnol Biofuels  (2018) 11:136 
TtgDEF and TtgGHI [18]. While the action of these and 
other RND-type efflux systems on antibiotics and aro-
matic compounds is well-studied, their effect on short-
chain alcohols, particularly relevant as next-generation 
biofuels, is thus far not known.
Moreover, a large-scale screen for identification of 
bacterial efflux pumps acting on biofuels returned no 
candidates for the short-chain alcohols n-butanol and 
isobutanol [5]. Together with several other attempts 
to identify efflux pumps for biofuels [19, 20], this led to 
the assumption that RND-type efflux pumps do not act 
on short-chain alcohols [4]. A more recent study applied 
random mutagenesis to the AcrAB-TolC efflux pump of 
E. coli, leading to the identification of mutations which 
allow export of n-butanol, isobutanol, and n-heptanol 
[21]. The pump was introduced into n-butanol-produc-
ing E. coli and shown to increase titers [6]. Unfortunately, 
this approach for engineering efflux pumps is tedious and 
limited by the plasticity of the native pump for broad-
ening its substrate specificity with respect to the target 
compound. Hence, the discovery of efflux pumps acting 
natively on a desired target product is a promising alter-
native approach for improving the tolerance of microbial 
production strains to support metabolic engineering for 
biofuel production.
We show that controlled expression of the TtgABC 
efflux system led to a strong increase in survival rate of 
P. putida DOT-T1E exposed to high concentrations of 
n-butanol, isobutanol, isoprenol, and isopentanol. We 
observed increased extracellular n-butanol concentra-
tions when cells expressing the efflux pump were incu-
bated in n-butanol containing media, indicating active 
efflux. This suggests that the TtgABC efflux pump can be 
used to improve production of a number of short-chain 
alcohols. On the other hand, we found that growth rates 
in n-butanol and isopentanol were not increased when 
expressing the pump, hinting at the limitations of growth 
assays for the identification of efflux pumps with novel 
functions. To our knowledge, this is the first report of 
a native RND-type efflux pump shown to export short-
chain alcohols.
Results
Expression of efflux pumps can be toxic and their oper-
ation requires energy [22], which implies a tradeoff 
between the benefit and burden of pump expression in 
toxic environments [23]. Therefore, the function of an 
efflux pump critically depends on the level of expres-
sion, which must be fine-tuned to maximize its effect 
while minimizing the burden. To gain quantitative con-
trol of expression and fine-tune expression levels to 
avoid a negative effect on cell survival from overexpres-
sion, we placed the TtgABC operon under control of the 
l-arabinose inducible promoter PBAD on a broad host 
range plasmid (BBR1) and transformed it into P. putida 
DOT-T1E (“Methods”). The plasmid remained stable in P. 
putida for about 2 days without selective antibiotic while 
expressing TtgABC (Additional file  1: Figure S1). In E. 
coli, induction via the PBAD promoter was shown to result 
in non-homogenous expression levels, whereby different 
sub-populations exhibit either high or no expression at 
intermediate inducer concentrations [24]. Since this phe-
nomenon would have complicated observing an effect 
of the pump on toxic substances at intermediate expres-
sion levels, we first tested whether expression via PBAD 
is homogenous in the case of P. putida by placing GFP 
under control of PBAD and determining fluorescence after 
induction with 0, 1, 10, and 100 mM l-arabinose. Using 
flow cytometry, we found that GFP fluorescence was 
quantitative and homogenous (Additional file  2: Figure 
S2), demonstrating that the promoter can be used effi-
ciently with P. putida for fine-tuning of expression levels.
To determine the burden of TtgABC pump expression 
in P. putida, we grew the plasmid-carrying strain with 
different inducer concentrations. Growth was unaffected 
when using up to 50 mM of l-arabinose (Fig. 1a). Induc-
tion with very high levels of l-arabinose (100 mM) led to 
a prolonged lag-phase of about 2  h, but the strain then 
fully recovered growth. For comparison, we expressed 
TtgABC in an E. coli strain engineered to give homoge-
nous expression using PBAD [25]. We found that TtgABC 
expression in this strain inhibits growth starting from 
l-arabinose concentrations as low as 1 μM (Fig. 1b), indi-
cating that transfer of the pump to other strains may be 
challenging due to toxicity (see “Discussion”).
We next determined the inducer concentrations, 
induction times, and growth stage which maximize the 
effect of TtgABC expression on survival in high concen-
trations of n-butanol (“Methods”). Although previous 
results indicated that P. putida DOT-T1E could grow in 
the presence of up to 6% n-butanol (v/v) after long-term 
adaptation [12], these results could not be reproduced 
by us or others [26]. Instead, we observed that the wild-
type strain could survive up to 1.9% of n-butanol for 2 h, 
and that its tolerance as measured by growth or sur-
vival did not increase even after 2 months of adaptation 
(“Methods”).
The TtgABC plasmid-carrying strain was then grown 
with and without induction, and the plasmid-free wild-
type strain was grown with l-arabinose as additional 
control. Induction of TtgABC expression with 1.5  mM 
l-arabinose and growth to stationary phase resulted in the 
largest increase of survival rate, and these conditions were 
chosen for all subsequent experiments. Note that TtgABC 
expression did not affect growth up to 50 mM l-arabinose 
(cf. Fig. 1a). After normalizing the cell densities, cells were 
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incubated with 1.9% n-butanol, 2.2% isobutanol, 1.5% 
isoprenol, or 0.7% isopentanol for 2  h, which represent 
slightly sub-lethal concentrations. Survival rates were cal-
culated by sampling the number of living cells before and 
after incubation (Fig.  2, “Methods”). For isobutanol and 
isoprenol, survival of the wild-type was at least an order 
of magnitude higher compared to the plasmid-carrying, 
non-induced variants. This indicates that the presence of 
the plasmid may decrease survival, which could limit the 
observable effect in strains expressing the pump. For each 
of the four alcohols tested, survival of the cells expressing 
TtgABC was at least tenfold higher compared to the non-
induced and wild-type strains.
To assess whether the observed increase in survival 
was indeed due to efflux of the alcohol, rather than a side 
effect or general stress response due to expressing the 
membrane protein, we compared extracellular n-butanol 
concentrations of non-induced and induced cells after 
incubation for 110 min with 0.2% n-butanol via gas chro-
matography with a flame ionization detector (GC-FID, 
“Methods”). The rationale for this approach is that strains 
with higher efflux accumulate less intracellular n-butanol, 
leading to higher measurable extracellular concentra-
tions. The approach was previously used to measure 
n-butanol efflux [21]. We found a significant increase of 
5.8% (t test, p value < 0.05) in extracellular n-butanol con-
centrations of induced cells, which corresponds to about 
2.9 × 10−8 mol gDW−1 s−1 more efflux of n-butanol from 
induced cells compared to non-induced cells. We deter-
mined the viable cell numbers before and after incuba-
tion to ensure that cells were not dying, since this could 
have led to a release of the alcohol due to membrane 
disintegration (“Methods”). Hence, our results indicate 
active efflux of n-butanol in cells expressing TtgABC.
The inner membrane pump of TtgABC is TtgB, which 
is the component responsible for substrate binding. TtgB 
is homologous to AcrB in the AcrAB-TolC efflux pump 
of E. coli (65% amino acid sequence similarity). Three 
individual point mutations of AcrB (M355L, I466, S880P) 
were previously shown to allow export of n-butanol, isob-
utanol, and n-heptanol in E. coli [21]. Sequence align-
ment revealed that the same amino acids are present at 
the corresponding loci of TtgB, with strongly conserved 
regions surrounding M355 and I466. To test whether 
increased efflux of n-butanol could be achieved in 
TtgABC, we applied each of the three point mutations, as 
well as the combination of the three, at the corresponding 
loci of TtgB (“Methods”). We found that each of the three 
mutations, as well as their combination, resulted in a 
decrease of survival rate compared to the wild-type strain 
(not shown). This may indicate structural differences of 
the inner membrane pumps, despite their homology, or 
a generally higher specificity of TtgB to n-butanol, com-
pared to AcrB, preventing a further increase of n-butanol 
efflux in TtgABC.
To assess whether the effect of efflux pump expression 
on cell survival implies faster growth in biofuels, we grew 
the induced and non-induced plasmid-carrying strains, 
as well as the plasmid-free wild-type strain, in a plate 
reader with a range of n-butanol and isopentanol concen-
trations (Figs. 3, 4). Growth rates were largely unaffected 
up to concentrations of 0.125% (v/v), and the wild-type 
strain grew slightly faster (0.26–0.35  h−1) compared 
to non-induced (0.19–0.34  h−1) and induced (0.18–
0.31 h−1) plasmid-carrying strains in both alcohols. The 
effect was even more pronounced at 0.25% (v/v), where 
Fig. 1 Toxicity of TtgABC expression. The pBbB8k‑TtgABC plasmid 
was introduced into P. putida DOT‑T1E and E. coli DP10, and efflux 
pump expression was induced using different concentrations of 
l‑arabinose. Growth curves indicate a prolonged lag‑phase when 
inducing expression with 100 mM l‑arabinose in P. putida (a), 
while growth of E. coli is strongly affected starting from inducer 
concentrations of 1 µM (b)
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growth of all strains was slightly affected, and the wild-
type strain grew faster (0.23–0.28 h−1) compared to the 
non-induced (0.14–0.21 h−1) and induced (0.11–0.2 h−1) 
plasmid-carrying strains. Moreover, there was no differ-
ence in growth rates between non-induced and induced 
strains for any of the tested concentrations. To account 
for the possibility of oxygen limitation in plate readers 
due to the small volumes used, we also tested growth in 
larger volumes (Additional file 3: Figure S3, “Methods”). 
Without alcohol, growth rates were higher compared to 
the plate reader and similar for all strains (0.53 h−1). With 
0.5% n-butanol, growth rates of the wild-type and non-
induced strains were slightly higher (0.29 h−1) compared 
to the induced strain (0.26  h−1). Hence, the observed 
effect of TtgABC on survival in highly toxic conditions 
does not translate into increased growth in less toxic bio-
fuel concentrations. Accordingly, growth assays could not 
have identified the observed effect of the TtgABC efflux 
pump on short-chain alcohols.
Methods
Plasmid construction and survival assays
We amplified ttgABC (5762  bp) from the genome of P. 
putida DOT-T1E and cloned it on a broad host range 
plasmid (BBR1) between the l-arabinose inducible PBAD 
promoter and double terminator using Gibson Assembly. 
Fig. 2 TtgABC expression increases survival of Pseudomonas putida DOT‑T1E in biofuels. Fraction of P. putida DOT‑T1E cells surviving 2 h of 
incubation with a 1.9% n‑butanol b 2.2% isobutanol, c 1.5% isoprenol, and d 0.7% isopentanol. Cells carrying TtgABC on a plasmid with l‑arabinose 
inducible promoter were grown with  (ttgABC+) or without  (ttgABC−) inducer. Plasmid‑free wild‑type cells (WT) were grown with l‑arabinose as 
control. Ratios were obtained by sampling viable cell numbers before and after incubation. The error bars indicate minimum and maximum of 3–6 
biological replicates
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The final construct, termed pBbB8k-TtgABC after the 
Bgl-Brick standard [27] has a length of 9529 bp and fur-
ther contains araC and Kanamycin resistance marker. For 
measuring expression levels, we created another plasmid 
containing GFP between the PBAD promoter and double 
terminator. The plasmids were transformed into P. putida 
DOT-T1E and E. coli DP10 [25] using electroporation 
(Bio-Rad MicroPulser).
For the survival assays, three to six colonies were inoc-
ulated in LB medium with 1.5 mM (induced) and with-
out (non-induced) l-arabinose and incubated shaking at 
200  rpm and 30  °C overnight. After reaching stationary 
phase, all samples were diluted to an equal optical density 
of 0.1 at 600 nm, and 2 mL of diluted culture (approxi-
mately 1.6 × 108 cells) was incubated shaking at 200 rpm 
and 30 °C in an airtight 15-mL plastic tube with the cor-
responding alcohol for 2  h. Diluted cell cultures were 
plated on selective medium (plasmid-carrying variants) 
and LB (plasmid-free WT) before and after incubation, 
and colonies were counted to determine the percent of 
surviving cells.
Long‑term adaptation of P. putida to n‑butanol
Pseudomonas putida DOT-T1E was grown for 2 months 
in 20  mL LB medium with 33  mM l-arabinose, 0.5% 
n-butanol, and 50  µg/mL rifampycin. The medium was 
renewed daily by sub-culturing of 100  µL into fresh 
medium. After 1 month, the strain was split into two cul-
tures. One culture was continued with 0.5% n-butanol in 
the medium, while the other was exposed to increasing 
concentrations of up to 1% n-butanol, with renewal of 
medium after reaching a visible density (approximately 
every 3 days). After 2 months, the strains were exposed to 
a range of n-butanol concentrations to test for increased 
tolerance. No difference was observed in survival or 
growth between the strains undergoing the long-term 
adaptation and the original wild-type strains.
Quantification of extracellular n‑butanol using GC‑FID
Three biological replicates were grown overnight with 
and without 1.5  mM l-arabinose as described in “Plas-
mid construction and survival assays”. Cell numbers were 
equalized by determining optical density and transferring 
Fig. 3 TtgABC expression does not increase growth of P. putida DOT‑T1E in n‑butanol. Growth of P. putida DOT‑T1E without plasmid (WT), without 
induction  (ttgABC−), and with induction  (ttgABC+) in 0% (a), 0.25% (b), and 0.5% (c) n‑butanol. Growth rates of the wild‑type strain are slightly 
higher, and there is no increase in growth rate due to TtgABC expression (d)
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an adjusted volume of ~ 50  mL at OD600 of 1.38 into 
centrifuge falcons. Assuming 1 OD600 unit corresponds 
to 8 × 108  cells  mL−1, this density corresponds to about 
5.5 × 1010 cells. Samples were split in half and cultures 
were centrifuged three times at 4000×g and washed with 
PBS at pH = 6.5. The last pellet was re-suspended in PBS 
with 0.2% n-butanol to reach a final weight of 1 g, roughly 
half of which were cells. Cells were incubated at room 
temperature for 110 min, and then centrifuged at 4000×g. 
250 µL of supernatant was added to 250 µL of ethyl acetate 
with isoprenol as internal standard, vigorously vortexed 
for 15 min, and centrifuged at 22×g for 1 min. 100 µL of 
the organic phase was then removed for further analysis.
Alcohols were quantified using a Tr-Wax column 
(0.25 mm by 30 m, 0.25-μm film thickness; Thermo Elec-
tron) on a Focus GC apparatus with a TriPlus autosampler 
(Thermo Electron). Hydrogen was used as a carrier, and 
was set at a constant pressure of 300 kPa, with the inlet 
temperature set to 200  °C. The oven program was 40  °C 
for 1.5 min and then it was increased from 40 to 110  °C 
at 15 °C min−1. Samples were normalized using isoprenol 
as internal standard and quantified using authentic stand-
ards. The measurements of the three replicates of induced 
and non-induced strains are shown in Additional file 4.
To test whether cells were dying during incubation, 
diluted cell cultures were plated before and after incuba-
tion with 0.2 and 1% n-butanol, and the resulting colo-
nies counted. Although we observed a slight decrease in 
cell numbers, this is likely due to a loss of sample when 
extracting the supernatant, because cell counts were sim-
ilar at 0.2 and 1% n-butanol (Additional file 4). Moreover, 
there was no significant difference in cell counts between 
induced and non-induced cells after incubation (t test, 
p value 0.26), indicating that pump expression does not 
lead to cell death under these conditions.
Transfer of point mutations from AcrB to TtgB
Three mutations of AcrB were previously shown to indi-
vidually increase efflux of n-butanol, isobutanol, and 
n-heptanol [21]. We applied the three point mutations 
M355L, I466F, and S878P (corresponding to S880P in 
the aligned AcrB) individually, and the combination of 
Fig. 4 TtgABC expression does not increase growth of P. putida DOT‑T1E in isopentanol. Growth of P. putida DOT‑T1E without plasmid (WT), without 
induction  (ttgABC−), and with induction  (ttgABC+) in 0% (a), 0.25% (b), and 0.5% (c) isopentanol. Growth rates of the wild‑type strain are slightly 
higher, and there is no increase in growth rate due to TtgABC expression (d)
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the three, to TtgB by PCR amplification with mismatch 
primers and Gibson Assembly of the resulting ampli-
cons. The created constructs pBbB8k-TtgABC[M355L], 
pBbB8k-TtgABC[I466F], pBbB8k-TtgABC[S878P], and 
pBbB8k-TtgABC[M355L,I466F,S878P] were sequenced 
and transformed into P. putida DOT-T1E via electropo-
ration. The strains were then subjected to the survival 
assay for n-butanol described in “Plasmid construction 
and survival assays”.
Growth curves
Growth rates were estimated via a microplate reader 
kinetic assay. Overnight cultures of P. putida grown in LB 
medium at 30 °C were diluted 1:100 into fresh LB media 
with either 1.5  mM (induced) or 0  mM (non-induced) 
l-arabinose and various concentrations of twofold 
diluted n-butanol or isopentanol in 96-well plates (Fal-
con, 353072). Plates were sealed with a gas-permeable 
microplate adhesive film (VWR, USA), and then opti-
cal density and fluorescence were monitored for 22 h in 
an Infinite F200 Pro (Tecan Life Sciences, San Jose, CA) 
plate reader at 30  °C. Optical density was measured at 
590  nm every 15  min. In between reads, the plate was 
shaken at a linear amplitude of 6 mm. All data were ana-
lyzed using custom Python scripts. Growth rates were 
calculated via a 10-timepoint sliding window on optical 
densities normalized to a 1-cm path length, where the 
maximal slope with an r2 > 0.95 was reported as the maxi-
mal growth rate. Growth curves were also done in 15 mL 
conical tubes containing 3 mL medium (Additional file 3: 
Figure S3), incubated shaking at 200 rpm at 30 °C. Optical 
densities for this experiment were measured at 600 nm.
Discussion
Short-chain alcohols are of great interest as biofuels 
because of their high energy–density, superior transport 
capabilities, and possibility of directly replacing common 
engine fuels as drop-ins. Several engineering strategies 
demonstrated the successful production of short-chain 
alcohols, including n-butanol, isobutanol, isopentanol, 
and isoprenol using E. coli [28–31]. However, their pro-
duction is strongly affected by the toxicity of the product, 
leading to suboptimal yields. Several examples demon-
strate that the use of efflux pumps can confer increased 
product yields [4–7]. For example, expression of the ATP-
binding cassette transporter MdlB of E. coli increased 
tolerance to and production of isopentenol, although no 
effect on other short-chain alcohols was observed [32]. 
This suggests that MdlB acts on isopentenol, even though 
efflux was not shown directly.
It was considered unlikely that efflux pumps of the 
type RND act on short-chain alcohols, because all pumps 
tested so far did not have an effect on these biofuels [4]. 
For example, knockout of AcrAB in E. coli did not affect 
cell survival in high concentrations of ethanol or 1-pro-
panol compared to the wild-type strain, regardless of 
whether or not the pump was induced with the mar phe-
notype [19]. The authors concluded that the AcrAB-TolC 
efflux pump does not act on short-chain alcohols. Simi-
larly, although mutations in AcrA increased tolerance 
of E. coli to isobutanol, measured by optical density of 
the cultures after treatment with the alcohol for 24 h, its 
knockout reduced tolerance [20]. This suggests that AcrA 
does not have a (positive) effect on isobutanol tolerance 
with respect to growth.
Moreover, in a large-scale screening approach [5], 
43 efflux pumps, including TtgABC and AcrAB-TolC, 
were tested for their effect on seven relevant biofuels. 
All pumps were cloned into E. coli, and the resulting 
library of strains was challenged with the biofuels result-
ing in competition for growth. Even though several efflux 
pumps acting on other biofuels were identified by the 
study, no pump was found to act on n-butanol or iso-
pentanol. Specifically, TtgABC was found not to have 
an effect on these compounds. However, the study dif-
fers from the approach presented here in two important 
aspects: first, E. coli was used as a host to express the het-
erologous pumps, and second, growth, rather than sur-
vival, was used to assess biofuel toxicity. We found that 
expression of TtgABC in E. coli inhibits growth (Fig. 1b), 
indicating that toxicity of the heterologous pump could 
have masked its effect on biofuel tolerance. Moreover, we 
also did not observe any effect of the pump on growth 
of P. putida in medium supplemented with low concen-
trations of biofuels (cf. Fig. 3). Hence, it is likely that the 
function of the pump is to improve survival under highly 
toxic conditions, rather than enabling faster growth. 
Consequently, a competitive growth assay could not have 
identified the effect of the TtgABC pump on biofuels.
We expect that the production and recovery of the 
short-chain alcohols n-butanol, isobutanol, isopentanol 
and isoprenol can be directly improved by expressing 
TtgABC in the production strain. We only tested these 
four short-chain alcohols here, and found that TtgABC 
acts on each of them. It is therefore likely that the pump 
also acts on other short-chain alcohols, many of which are 
promising biofuel candidates: for example, the structur-
ally similar 1-propanol, isopropanol, 1-pentanol, prenol, 
and 2-methyl-1-butanol have been successfully produced 
with engineered bacteria [28, 33–35]. To our knowledge, 
no efflux pump is known yet to act on these compounds, 
and TtgABC would be a promising candidate to test for 
decreasing toxicity and improving their production.
The observed toxicity of expressing the pump in E. coli 
(cf. Fig.  1b) indicates that directly transferring TtgABC 
to other strains may be challenging. Recently identified 
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mutations in E. coli leading to a reduced burden of express-
ing membrane proteins may help to reduce the toxicity of 
the efflux pump [36], as it may chaperone overexpression 
[37]. Strategies for regulating membrane protein produc-
tion via genetic circuits are also promising [6]. Moreover, 
P. putida may itself serve as production host, and several 
studies have already demonstrated that the strain can be 
engineered as a robust biocatalyst. Plenty of genetic tools 
are available for modifying the genetic potential of the 
strain [38–40]. It has been metabolically engineered for 
the production of a large variety of compounds, includ-
ing polyketides, non-ribosomal peptides, rhamnolipids, 
and aromatic and non-aromatic compounds (reviewed in 
[41]). The strain has also great potential for the direct pro-
duction of biofuels from lignocellulosic biomass, as it has 
been successfully engineered for production of aromatic 
compounds from lignin components [42, 43]. The strain 
was also successfully engineered to grow under anaerobic 
conditions [44–46], and it was used in two-phase liquid 
extraction systems [47, 48], facilitating the production and 
extraction of toxic apolar compounds in bioreactors.
More specifically, P. putida was engineered for pro-
duction of n-butanol by introducing the biosynthetic 
pathway from C. acetobutylicum [49]. Since P. putida 
degrades n-butanol [13], it will be important to knock 
out the corresponding genes to further increase yields 
[50]. Hence, the next step will be to express TtgABC in 
a production strain deficient of n-butanol consumption 
and determine the increase in yield. Since we observed 
a potential burden of the introduced plasmid on survival 
and growth (cf. Figs. 2b, c), an alternative approach would 
be to modify the regulatory region of TtgABC on the 
genome to obtain control over efflux pump expression 
without the need of a plasmid, e.g., using classical trans-
poson-based techniques [40]. Although a recent study 
indicates that genome editing using lambda Red based 
recombineering of P. putida KT2440 is possible, our 
attempts with the strain DOT-T1E were not successful. 
An alternative approach would be to identify plasmids 
which do not affect the strain when exposed to toxic sub-
stances, such as plasmids shown to represent a minimal 
burden for growth in several strains of Pseudomonas [51]. 
With the help of such approaches, the effect of TtgABC 
expression on tolerance to short-chain alcohols can be 
further optimized with the aim of maximizing yields in 
biofuel production strains.
Conclusions
We showed that the TtgABC efflux pump in P. putida 
DOT-T1E improved tolerance to four short-chain alcohols 
and increases efflux of n-butanol. It is likely that the efflux 
pump acts on other yet undetermined compounds of indus-
trial relevance, particularly short-chain alcohols. Controlled 
expression of the efflux pump and identification of the con-
ditions which maximize its effect on tolerance open the pos-
sibility of directly testing the effect of the pump on other 
toxic substances, further engineering its substrate specific-
ity, and its use in metabolic engineering applications.
Moreover, we demonstrated that the specific condi-
tions and levels of pump expression, as well as the type 
of assay used to determine toxicity, can have a great influ-
ence on the observed effect of the efflux pump. Hence, 
our results indicate that the in-depth study of an indi-
vidual efflux pump, in addition to large-scale screen-
ing approaches, may lead to the identification of efflux 
pumps with novel functions. The techniques employed 
here are easy to implement and can be readily applied to 
other strains and efflux pumps. Consequently, it is possi-
ble that novel efflux pump functions for use in microbial 
production of biofuels or other toxic substances will be 
discovered using the presented approach.
This is the first report of a native RND-type efflux 
pump acting on short-chain alcohols, an important class 
of next-generation biofuels. Together with the availability 
of genetic tools, catabolic diversity, versatile metabolism 
and high intrinsic tolerance of the strain to various toxic 
substances [52], we believe that P. putida will become 
an important biocatalyst for biofuels. To this end, the 
TtgABC efflux pump will provide a valuable tool for 
reducing toxicity and increasing yields.
Additional files
Additional file 1: Figure S1. Plasmid stability of pBbB8k‑TtgABC in 
Pseudomonas putida DOT‑T1E. The plasmid‑carrying strain was grown 
for 5 consecutive days with 2 mM L‑arabinose for inducing expression 
of TtgABC and without kanamycin. The medium was renewed once per 
day. Plasmid stability was determined by plating on kanamycin plates and 
comparison of viable cell numbers.
Additional file 2: Figure S2. Cell‑level GFP expression using the L‑arab‑
inose inducible  PBAD promoter in Pseudomonas putida DOT‑T1E. Cells car‑
rying the pBbB8k‑GFP plasmid were induced overnight without (brown), 
with 1 mM (red), 10 mM (purple), and 100 mM (green) L‑arabinose. 
Cell‑level fluorescence of GFP was measured using flow cytometry. The 
distributions indicate a homologous and quantitative increase of expres‑
sion at the cell level.
Additional file 3: Figure S3. TtgABC expression does not increase growth 
of P. putida DOT‑T1E in n‑butanol. Growth of P. putida DOT‑T1E without 
plasmid (WT), without induction (ttgABC-), and with induction (ttgABC+) 
in 0% (a) and 0.5% (b) n‑butanol in 15 mL conical tubes containing 3 mL 
medium. Similar to the results obtained from the plate reader (cf. Fig. 3), 
growth of the wild‑type strain is slightly faster with and without n‑butanol, 
and TtgABC expression does not increase growth in n‑butanol.
Additional file 4. Quantification of extracellular n‑butanol using GC‑FID. 
The spreadsheet contains the estimated fraction of viable cells after 
incubation in PBS containing 0.2 and 1% n‑butanol, and the measure‑
ment values of quantified extracellular n‑butanol in induced (ttgABC+) and 
non‑induced strains (ttgABC-). The original readings for n‑butanol and the 
internal standard isoprenol are shown, as well as the n‑butanol measure‑
ments normalized by the standard, and the derived concentrations as 
volume per volume and milligrams per milliliter. The inlay shows the 
n‑butanol standard curve, indicating that concentrations are in a linear 
measurement range.
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